-
1
Importance of adherence for efficacy of hepatitis C combined therapy
Published 2013-01-01Subjects: Get full text
Article -
2
-
3
-
4
Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
Published 2017-01-01Subjects: “…Chronic Hepatitis B; Hepatitis B Surface Antigen; Kinetics; Pegylated Interferon Alfa-2a…”
Get full text
Article -
5
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
Published 2020-01-01Subjects: Get full text
Article -
6
A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm
Published 2020-06-01Subjects: Get full text
Article -
7
Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
Published 2022-05-01Subjects: Get full text
Article -
8
Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases
Published 2018-07-01Subjects: Get full text
Article